Medmonk

Medmonk

Explains primary non-adherence and argues that cost, coverage barriers, lack of transparency, and logistics prevent many new prescriptions from ever becoming treatment; positions Medmonk as a way to reduce drop-off at the point of access.

Medmonk

Focuses on the gap between diagnosis and treatment start in rare disease, emphasizing prior authorization, benefits investigation, specialty-pharmacy coordination, affordability, and handoff leakage.

Medmonk

Frames financial access as a digital-health workflow problem and highlights integrated benefit verification, prior authorization management, and financial assistance workflows to reduce abandonment.

Medmonk

Argues that pharmacy logistics alone do not solve access; delays still occur in intake quality, documentation readiness, appeals, funding coordination, and HUB-to-specialty-pharmacy handoffs.

Medmonk

Describes copay cards, charitable foundations, and patient-assistance programs for expensive specialty drugs, and explains how Medmonk helps automate eligibility, enrollment, and prior authorization support.